Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes.

[1]  S. Vannucci,et al.  Winner of the 1988 NAASO Young Investigator Award. Regulation of fat cell adenylate cyclase in young Zucker (fa/fa) rats: alterations in GTP sensitivity of adenosine A1 mediated inhibition. , 1990, International journal of obesity.

[2]  J. Flier,et al.  Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. , 1989, Molecular endocrinology.

[3]  M. Birnbaum,et al.  Pretranslational suppression of an insulin-responsive glucose transporter in rats with diabetes mellitus. , 1989, Science.

[4]  G. Bell,et al.  Regulation of glucose transporter messenger RNA in insulin-deficient states , 1989, Nature.

[5]  J. Berger,et al.  Decreased expression of the insulin-responsive glucose transporter in diabetes and fasting , 1989, Nature.

[6]  M. White,et al.  A defective intramolecular autoactivation cascade may cause the reduced kinase activity of the skeletal muscle insulin receptor from patients with non-insulin-dependent diabetes mellitus. , 1989, The Journal of biological chemistry.

[7]  R. DiMarchi,et al.  Effect of insulin and insulin-like growth factors I and II on phosphatidylinositol and phosphatidylinositol 4,5-bisphosphate breakdown in liver from humans with and without type II diabetes. , 1989, The Journal of biological chemistry.

[8]  K. Kaestner,et al.  Sequence, tissue distribution, and differential expression of mRNA for a putative insulin-responsive glucose transporter in mouse 3T3-L1 adipocytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. James,et al.  Molecular cloning and characterization of an insulin-regulatable glucose transporter , 1989, Nature.

[10]  D. S. Gray.  Diagnosis and prevalence of obesity. , 1989, The Medical clinics of North America.

[11]  G. Hitman,et al.  Genes and diabetes mellitus. , 1989, British medical bulletin.

[12]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[13]  R. Eckel,et al.  Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia. , 1988, The Journal of clinical investigation.

[14]  J. Olefsky,et al.  Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes. , 1988, The American journal of medicine.

[15]  C. Kahn,et al.  Insulin inhibits pertussis toxin-catalyzed ADP-ribosylation of G-proteins. Evidence for a novel interaction between insulin receptors and G-proteins. , 1988, The Journal of biological chemistry.

[16]  J. Olefsky,et al.  Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. , 1988, The Journal of clinical investigation.

[17]  C. Kahn,et al.  The insulin receptor and the molecular mechanism of insulin action. , 1988, The Journal of clinical investigation.

[18]  A. Ullrich,et al.  Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity , 1988, Cell.

[19]  J. Foley.  Mechanisms of impaired insulin action in isolated adipocytes from obese and diabetic subjects. , 1988, Diabetes/metabolism reviews.

[20]  G. Dohm,et al.  An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. , 1988, The Journal of clinical investigation.

[21]  P. Cuatrecasas,et al.  In search of a second messenger for insulin. , 1988, The American journal of physiology.

[22]  R. Farese,et al.  Insulin-induced glycerolipid mediators and the stimulation of glucose transport in BC3H-1 myocytes. , 1988, The Journal of biological chemistry.

[23]  T. Watts,et al.  An autocrine factor from Reuber hepatoma cells that stimulates DNA synthesis and acetyl-CoA carboxylase. Characterization of biologic activity and evidence for a glycan structure. , 1988, The Journal of biological chemistry.

[24]  R. DeFronzo.  The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.

[25]  D. James,et al.  Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein , 1988, Nature.

[26]  J. Gerich.  2 Role of insulin resistance in the pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus , 1988 .

[27]  C. Kahn,et al.  Alterations in insulin receptor autophosphorylation in insulin resistance: correlation with altered sensitivity to glucose transport and antilipolysis to insulin. , 1988, The Journal of clinical endocrinology and metabolism.

[28]  S. O’Rahilly,et al.  Pathogenesis of NIDDM--a disease of deficient insulin secretion. , 1988, Bailliere's clinical endocrinology and metabolism.

[29]  J. Olefsky,et al.  Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus. , 1988, The Journal of clinical investigation.

[30]  M. Kinter,et al.  Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphate contains galactosamine and D-chiroinositol. , 1988, Biochemical and biophysical research communications.

[31]  J. Exton,et al.  Insulin and oxytocin effects on phosphoinositide metabolism in adipocytes. , 1988, The Journal of biological chemistry.

[32]  M. Lavau,et al.  Increased in vivo glucose utilization in 30-day-old obese Zucker rat: role of white adipose tissue. , 1988, The American journal of physiology.

[33]  G. Dohm,et al.  Heterogeneity of human liver, muscle, and adipose tissue insulin receptor. , 1988, Biochemical and biophysical research communications.

[34]  J. Shafer,et al.  Insulin stimulated protein phosphorylation in human plasma liver membranes: detection of endogenous or plasma membrane associated substrates for insulin receptor kinase. , 1987, Biochemical and biophysical research communications.

[35]  S. J. Taylor,et al.  Guanine-nucleotide and hormone regulation of polyphosphoinositide phospholipase C activity of rat liver plasma membranes. Bivalent-cation and phospholipid requirements. , 1987, The Biochemical journal.

[36]  P. Björntorp,et al.  Glucose uptake in human adipose tissue. , 1987, Metabolism: clinical and experimental.

[37]  P. Strålfors,et al.  Phospho-dephospho-control by insulin is mimicked by a phospho-oligosaccharide in adipocytes , 1987, Nature.

[38]  W. Pories,et al.  Long-term effect of insulin on glucose transport and insulin binding in cultured adipocytes from normal and obese humans with and without non-insulin-dependent diabetes. , 1987, The Journal of clinical investigation.

[39]  O. Rosen.  After insulin binds. , 1987, Science.

[40]  I. Goldfine.  The insulin receptor: molecular biology and transmembrane signaling. , 1987, Endocrine reviews.

[41]  W. Pories,et al.  Insulin-Receptor Kinase Activity of Adipose Tissue From Morbidly Obese Humans With and Without NIDDM , 1987, Diabetes.

[42]  I. Goldfine,et al.  Monoclonal antibodies to the human insulin receptor that activate glucose transport but not insulin receptor kinase activity. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[43]  A. Saltiel,et al.  Purification of a phosphatidylinositol-glycan-specific phospholipase C from liver plasma membranes: a possible target of insulin action. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[44]  G. Dohm,et al.  Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. , 1987, The Journal of clinical investigation.

[45]  L. Jarett,et al.  Identification of a novel insulin-sensitive glycophospholipid from H35 hepatoma cells. , 1987, The Journal of biological chemistry.

[46]  A. Ullrich,et al.  Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. , 1987, The Journal of biological chemistry.

[47]  W. Rutter,et al.  Replacement of lysine residue 1030 in the putative ATP-binding region of the insulin receptor abolishes insulin- and antibody-stimulated glucose uptake and receptor kinase activity. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Halestrap,et al.  Effects of glucagon and Ca2+ on the metabolism of phosphatidylinositol 4-phosphate and phosphatidylinositol 4,5-bisphosphate in isolated rat hepatocytes and plasma membranes. , 1987, The Biochemical journal.

[49]  G. Grunberger,et al.  Relationship of insulin binding and insulin-stimulated tyrosine kinase activity is altered in type II diabetes. , 1987, The Journal of clinical investigation.

[50]  D. Morgan,et al.  Acute insulin action requires insulin receptor kinase activity: introduction of an inhibitory monoclonal antibody into mammalian cells blocks the rapid effects of insulin. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[51]  H. Klein,et al.  Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. , 1987, The Journal of clinical investigation.

[52]  P. Cuatrecasas,et al.  Insulin stimulates the generation from hepatic plasma membranes of modulators derived from an inositol glycolipid. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Silverman,et al.  Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity. , 1986, The Journal of clinical investigation.

[54]  M. Houslay.  Insulin, glucagon and the receptor-mediated control of cyclic AMP concentrations in liver. Twenty-second Colworth medal lecture. , 1986, Biochemical Society transactions.

[55]  I. Simpson,et al.  Hormonal regulation of mammalian glucose transport. , 1986, Annual review of biochemistry.

[56]  O. Rosen,et al.  An antipeptide antibody that specifically inhibits insulin receptor autophosphorylation and protein kinase activity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[57]  H. Lodish,et al.  Sequence and structure of a human glucose transporter. , 1985, Science.

[58]  M. Hollenberg,et al.  Action of insulin modulated by pertussis toxin in rat adipocytes. , 1985, Canadian journal of physiology and pharmacology.

[59]  K. Jarnagin,et al.  The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signalling , 1985, Cell.

[60]  P. H. Seeburg,et al.  Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes , 1985, Nature.

[61]  L. Jarett,et al.  Intracellular mediators of insulin action. , 1985, Diabetes/metabolism reviews.

[62]  Á. Enyedi,et al.  Cyclic AMP‐dependent protein kinase and Ca2+‐calmodulin stimulate the formation of polyphosphoinositjdes in a sarcoplasmic reticulum preparation of rabbit heart , 1984, FEBS letters.

[63]  O. Wieland,et al.  Evidence that the insulin receptor‐associated protein kinase acts as a phosphatidylinositol kinase , 1984, FEBS letters.

[64]  M. Berridge.  Inositol trisphosphate and diacylglycerol as second messengers. , 1984, The Biochemical journal.

[65]  D. Lockwood,et al.  Cellular alterations responsible for insulin resistance in obesity and type II diabetes mellitus. , 1983, The American journal of medicine.

[66]  P. Arner,et al.  Studies of liver insulin receptors in non-obese and obese human subjects. , 1983, The Journal of clinical investigation.

[67]  P. Cuatrecasas,et al.  Phorbol esters stimulate the phosphorylation of receptors for insulin and somatomedin C. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[68]  C. Kahn,et al.  Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor. , 1982, Science.

[69]  L. Mandarino,et al.  Mechanism and Significance of Insulin Resistance in Non-insulin-dependent Diabetes Mellitus , 1981, Diabetes.

[70]  K. Alberti,et al.  Metabolic studies in unaffected co-twins of non-insulin-dependent diabetics. , 1981 .

[71]  J. Halter,et al.  Insulin secretion in diabetes mellitus. , 1981, The American journal of medicine.

[72]  J. Neel.  Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? , 1962, American journal of human genetics.

[73]  H. Himsworth.  DIABETES MELLITUS: ITS DIFFERENTIATION INTO INSULIN-SENSITIVE AND INSULIN-INSENSITIVE TYPES , 1936 .